Home › Scientific Tracks › Hematologic Malignancies

Hematologic Malignancies

Leukemia, lymphoma & transplant medicine

Track Chair

Prof. Nadia RahimiTehran University of Medical Sciences

Co-Chair

Dr. Dler AhmedHiwa Cancer Hospital, Slemani

About This Track

Modern management of blood cancers: molecular diagnostics, novel agents, transplantation, and building hematology capacity in the region.

8+

Sessions

40+

Speakers

100+

Abstracts Expected

Topics Covered

Acute leukemia: risk-adapted therapy
Lymphoma: from chemotherapy to targeted agents
Multiple myeloma treatment sequencing
Stem cell transplantation in the region
Molecular monitoring and MRD
CAR-T: present and future

Invited SpeakersView All Speakers →

Prof. Nadia Rahimi

Tehran University of Medical Sciences
Iran

View Profile →

Prof. Karel Vandermeer

Jules Bordet Institute, Brussels
Belgium

View Profile →

Abstract Categories

Basic and Translational Research — Hematologic Malignancies
Screening, Diagnosis and Imaging — Hematologic Malignancies
Treatment and Clinical Outcomes — Hematologic Malignancies
Supportive Care and Quality of Life — Hematologic Malignancies
Case Reports and Clinical Observations — Hematologic Malignancies

Learning Objectives

Apply risk stratification in acute leukemia
Sequence therapy in lymphoma and myeloma
Identify transplant-eligible patients and referral pathways
Understand MRD-guided treatment decisions

Join leading experts in hematologic malignancies

Submit your abstract and be part of this global scientific exchange.

Submit Abstract →All Tracks